These data suggested that AT1-AA has direct effect on migration of ovarian cancer cells through activating AT1 receptor, consistent with a previous report showing that Ang II-induced tumor cell invasion, angiogenesis and peritoneal dissemination are blocked by Ang II AT1-receptor antagonist[19]. The gene discussed is AGT; the disease is ovarian carcinoma.